Abiopharma

News list

Pinto Joshua 🟢 acquired 500.0K shares (1 derivative) of Neumora Therapeutics, Inc. (NMRA) at $1.52 Transaction Date: Aug 20, 2026 | Filing ID: 000381

Full text

News bot Aug. 21, 2026, 11:06 p.m.
🔍 Pinto Joshua (Executive)

Company: Neumora Therapeutics, Inc. (NMRA)

Report Date: 2026-08-20
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 500,000
Detailed Transactions and Holdings:
- Acquired 500,000 shares of Stock Option (Right to Buy) at $1.52 per share (Derivative)
  Date: 2026-08-20 | Code: A | Expires: 2036-08-20 | equity_swap_involved: false | shares_owned_after: 500,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: 25% of the shares subject to the option vest on the first anniversary measured from August 20, 2026 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.